
Jeffrey Fineman
Physician · BLUEMARK LLC OFFICE ALLY
Credentials: · ·
History
- Present
BLUEMARK LLC OFFICE ALLY · UCSF OUTPATIENT PHARMACY AT PARNASSUS
- 2023–2026
1984–1987
Research
Circulation · 2015 · 859 citations
New England Journal of Medicine · 1997 · 604 citations
Complex interplay between autophagy and oxidative stress in the development of pulmonary disease
Review · Redox Biology · 2020 · 387 citations

48 papers

43 papers · 2 as a fellow

36 papers

30 papers

25 papers
- AA
24 papers

22 papers

20 papers
Grants
- 2020–2030
National Heart, Lung, and Blood Institute · P01
Project lead · $5.2M · Florida International University
- 2017–2027
National Institute of Child Health and Human Development · R44
PI · $4.2M · Omniox, Inc.
- 2022–2027
Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease
National Heart, Lung, and Blood Institute · T32
Contact PI · $1.7M · University of California, San Francisco
- 2005–2027
Research Training in Pediatric Critical Care Medicine
National Institute of Child Health and Human Development · T32
Contact PI · $3.1M · University of California, San Francisco
Clinical trials
- 2014–2020
Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow
Principal investigator · Withdrawn · Phase 1
University of California, San Francisco
- 2015–2025
Pulmonary Hypertension Association Registry
Site PI · Recruiting
Pulmonary Hypertension Association, Inc.



